[11] [12] For weight management, NICE (TA875, TA664) recommends these medications for adults with a BMI of 35 kg/m or more (or 32.5 kg/m or more for people from South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean family backgrounds) who have at least one weight-related comorbidity and are receiving care through specialist weight management services
However, the medication remains attractive due to its generally low cost, wide availability, and favorable long-term safety profile
Its also approved for use in children ages 12 years and older with obesity
Studies on wound healing: effects of calcium D-pantothenate on the migration, proliferation and protein synthesis of human dermal fibroblasts in culture
But TRT alone is not a powerful weight loss tool